{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:06:05Z","timestamp":1784549165126,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008271","name":"LEO Pharma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010137","name":"Sanofi Espoir Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010137","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.rpth.2026.106628","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:28:45Z","timestamp":1777602525000},"page":"106628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Venous thromboembolic and bleeding risk in population with obesity hospitalized for an acute medical illness receiving enoxaparin for thromboprophylaxis"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1922-8879","authenticated-orcid":false,"given":"Walter","family":"Ageno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan I.","family":"Arcelus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Stroh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmina","family":"Djoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdel-Moneim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6334-8034","authenticated-orcid":false,"given":"Ekaterina","family":"Ponomareva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.106628_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","article-title":"Venous thromboembolism","volume":"398","author":"Khan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2026.106628_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejim.2023.11.017","article-title":"Event rates and risk factors for venous thromboembolism and major bleeding in a population of hospitalized adult patients with acute medical illness receiving enoxaparin thromboprophylaxis","volume":"121","author":"Gal","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.rpth.2026.106628_bib3","first-page":"S468","article-title":"Venous thromboembolism in acute medically ill patients: identifying unmet needs and weighing the value of prophylaxis","volume":"24","author":"Dobesh","year":"2018","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.rpth.2026.106628_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3400\/avd.ra.19-00115","article-title":"Recommendations for VTE prophylaxis in medically ill patients","volume":"13","author":"Skeik","year":"2020","journal-title":"Ann Vasc Dis"},{"key":"10.1016\/j.rpth.2026.106628_bib5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.11604\/pamj.2022.42.160.28278","article-title":"Evaluation of venous thromboembolism (VTE) risk assessment and thrombo-prophylaxis practices in hospitalized medical and surgical patients at Aga Khan Hospital Dar es Salaam: single-centre retrospective study","volume":"42","author":"Ismail","year":"2022","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.rpth.2026.106628_bib6","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1161\/CIRCULATIONAHA.109.921460","article-title":"Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study","volume":"121","author":"Holst","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2026.106628_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/joim.12299","article-title":"Obesity as a causal risk factor for deep venous thrombosis: a Mendelian randomization study","volume":"277","author":"Klovaite","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.rpth.2026.106628_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamacardio.2018.4537","article-title":"Cardiovascular risk factors associated with venous thromboembolism","volume":"4","author":"Gregson","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.rpth.2026.106628_bib9","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1182\/blood.2019003603","article-title":"Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis","volume":"135","author":"Darzi","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106628_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1163684","article-title":"Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin in inpatients with obesity","volume":"10","author":"Amin","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.rpth.2026.106628_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.107.709204","article-title":"Cardiovascular risk factors and venous thromboembolism: a meta-analysis","volume":"117","author":"Ageno","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2026.106628_bib13","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.amjmed.2005.03.012","article-title":"Obesity as a risk factor in venous thromboembolism","volume":"118","author":"Stein","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.rpth.2026.106628_bib15","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1016\/j.jval.2023.03.2561","article-title":"EPH215 yearly trend of obesity prevalence among hospitalized patients in the United States: 2017-2021","volume":"26","author":"Moon","year":"2023","journal-title":"Value Health"},{"key":"10.1016\/j.rpth.2026.106628_bib16","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Sch\u00fcnemann","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.106628_bib17","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/jth.15358","article-title":"Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation","volume":"19","author":"Martin","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106628_bib18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/17474086.2018.1517040","article-title":"Anticoagulation at the extremes of body weight: choices and dosing","volume":"11","author":"McCaughan","year":"2018","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.rpth.2026.106628_bib19","article-title":"Strategies involving low-molecular-weight heparin for the treatment and prevention of venous thromboembolism in patients with obesity: a systematic review and meta-analysis","volume":"14","author":"Liu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.rpth.2026.106628_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12959-019-0214-8","article-title":"Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in at-risk patient groups: pregnancy, elderly and obese patients","volume":"17","author":"Brenner","year":"2019","journal-title":"Thromb J"},{"key":"10.1016\/j.rpth.2026.106628_bib21","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1381\/096089206779319383","article-title":"Risk of venous thromboembolism and efficacy of thromboprophylaxis in hospitalized obese medical patients and in obese patients undergoing bariatric surgery","volume":"16","author":"Rocha","year":"2006","journal-title":"Obes Surg"},{"key":"10.1016\/j.rpth.2026.106628_bib22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.15386\/mpr-1372","article-title":"Association between obesity and venous thromboembolism","volume":"93","author":"Hotoleanu","year":"2020","journal-title":"Med Pharm Rep"},{"key":"10.1016\/j.rpth.2026.106628_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/M16-1860","article-title":"Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline update from the American College of Physicians","volume":"166","author":"Qaseem","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2026.106628_bib25","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Kahn","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.rpth.2026.106628_bib26","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.0000138928.83266.24","article-title":"Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients","volume":"110","author":"Leizorovicz","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2026.106628_bib27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group","volume":"341","author":"Samama","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106628_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(08)60202-0","article-title":"Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study","volume":"371","author":"Cohen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2026.106628_bib29","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","article-title":"The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2026.106628_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2010.01.057","article-title":"Risk factors for venous thromboembolism","volume":"56","author":"Goldhaber","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rpth.2026.106628_bib32","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3390\/medicina58091290","article-title":"Obesity as a risk factor for venous thromboembolism recurrence: a systematic review","volume":"58","author":"Ntinopoulou","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.rpth.2026.106628_bib33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4236\/ojpm.2012.24069","article-title":"The effects of obesity on venous thromboembolism: a review","volume":"2","author":"Yang","year":"2012","journal-title":"Open J Prev Med"},{"key":"10.1016\/j.rpth.2026.106628_bib34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1160\/TH13-01-0042","article-title":"Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients","volume":"111","author":"Wang","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106628_bib35","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1310\/hpj4908-740","article-title":"Appropriate enoxaparin dose for venous thromboembolism prophylaxis in patients with extreme obesity","volume":"49","author":"Shelkrot","year":"2014","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.rpth.2026.106628_bib36","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.amjsurg.2013.07.020","article-title":"Weight-based enoxaparin dosing for venous thromboembolism prophylaxis in the obese trauma patient","volume":"206","author":"Bickford","year":"2013","journal-title":"Am J Surg"},{"key":"10.1016\/j.rpth.2026.106628_bib37","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.thromres.2009.02.003","article-title":"Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients","volume":"125","author":"Rondina","year":"2010","journal-title":"Thromb Res"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926032863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926032863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:21:54Z","timestamp":1784546514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926032863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2475037926032863"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106628","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Venous thromboembolic and bleeding risk in population with obesity hospitalized for an acute medical illness receiving enoxaparin for thromboprophylaxis","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106628","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"106628"}}